Abstract: Following recent anthrax attacks, the attention of US public-health experts is turning to the potential use of smallpox by bioterrorists. Production of a new smallpox vaccine by Acambis (Cambridge, MA, USA) is to be accelerated, and both the US government and WHO are investigating whether any other companies can make additional vaccine stocks. On November 4 the US Centers for Disease Control and Prevention announced that it was preparing expert teams to respond to possible smallpox outbreaks.
Publication Year: 2001
Publication Date: 2001-12-01
Language: en
Type: article
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 5
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot